'Design, synthesis, and strategic use of small chemical probes toward identification of novel targets for drug development'.


Journal

Current opinion in chemical biology
ISSN: 1879-0402
Titre abrégé: Curr Opin Chem Biol
Pays: England
ID NLM: 9811312

Informations de publication

Date de publication:
06 2020
Historique:
received: 16 11 2019
revised: 10 03 2020
accepted: 10 03 2020
pubmed: 7 5 2020
medline: 18 5 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

Chemical probes are essential tools used to study and modulate biological systems. Here, we describe some of the recent scientific advancement in the field of chemical biology, as well as how the advent of new technologies is redefining the criteria of 'good' chemical probes and influencing the discovery of valuable drug leads. In this review, we report selected examples of the usage of linkered and linker-free chemical probes for target identification, biological discovery, and general mechanistic understanding. We also discuss the promises of chemogenomics libraries in phenotypic screens, as well as the limitation of their usage to identify the modulation of new targets and biology.

Identifiants

pubmed: 32375076
pii: S1367-5931(20)30034-X
doi: 10.1016/j.cbpa.2020.03.003
pii:
doi:

Substances chimiques

Limonins 0
Small Molecule Libraries 0
nimbolide 25990-37-8
Thalidomide 4Z8R6ORS6L
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-97

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Conflict of interest statement Nothing declared.

Auteurs

Maria Paola Castaldi (MP)

Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, USA. Electronic address: paola.castaldi@astrazeneca.com.

James Adam Hendricks (JA)

Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, USA.

Andrew X Zhang (AX)

Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH